Ownership history in Bayesian Capital Management, LP · 21 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in CVS HEALTH CORP (CVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 7,248 | -10,552 | -59.3% | 1.32% | $575K | $78.71 |
| 2025 Q3 | REDUCED | 17,800 | -49,700 | -73.6% | 0.27% | $1.3M | $74.17 |
| 2025 Q2 | REDUCED | 67,500 | -12,200 | -15.3% | 0.74% | $4.7M | $67.13 |
| 2025 Q1 | ADDED | 79,700 | +18,600 | +30.4% | 0.89% | $5.4M | $65.26 |
| 2024 Q3 | REDUCED | 61,100 | -110,300 | -64.4% | 0.45% | $3.8M | $59.15 |
| 2023 Q4 | REDUCED | 171,400 | -48,100 | -21.9% | 1.44% | $13.5M | $72.09 |
| 2023 Q3 | ADDED | 219,500 | +172,700 | +369.0% | 1.75% | $15.3M | $63.20 |
| 2023 Q2 | REDUCED | 46,800 | -13,279 | -22.1% | 0.35% | $3.2M | $62.07 |
| 2023 Q1 | ADDED | 60,079 | +24,900 | +70.8% | 0.55% | $4.5M | $66.17 |
| 2022 Q4 | ADDED | 35,179 | +31,979 | +999.3% | 0.48% | $3.3M | $82.42 |
As of 2025 Q4 — sorted by position size